newsfilter
← Latest News
Business Wire·

OmniAb Business Combination Approved by APAC Shareholders

APAC Shareholder Approval Obtained, Closing Scheduled for November 1, 2022 Ligand "Regular Way" and "Ex-Distribution" and OmniAb "When-Issued" Set to Begin Trading on October 25, 2022 Ligand Pharmaceuticals